Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA advisory committee votes in favor of Waylivra for familial chylomicronemia syndrome

May 11, 2018

KemPharm reports topline data from human abuse potential trial with KP-415 prodrug

May 11, 2018

CARB-X supports Talis' development of diagnostics to detect chlamydia and gonorrhea

May 11, 2018

SymBio enters joint research agreement with Keio University to evaluate Treakisym for SLE

May 11, 2018

Researchers present nanoencapsulated hepatocyte enzymes to fight alcohol intoxication

May 11, 2018

Phase I study of AVB-S6-500 demonstrates proof of mechanism

May 11, 2018

FDA identifies deficiencies during NDA review of Methylene Blue MMX

May 11, 2018

Lilly to acquire ARMO BioSciences

May 11, 2018

Phosphodiesterase PDE4 inhibitors patented byTakeda

May 11, 2018

MFN2 agonist restores mitochondrial trafficking in models of Charcot-Marie-Tooth disease type 2A

May 11, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...